Thursday, September 20, 2012

Drug May Help Social Withdrawal in Autism

An experimental drug showed promising results in treating the key symptom of social withdrawal in people with Fragile X syndrome, the most common known inherited cause of autism with intellectual disability, according to a recent clinical trial.
The drug, known as arbaclofen or STX209, is a derivative of the FDA-approved drug, baclofen, which is primarily used to treat muscle spasticity in conditions like cerebral palsy and is being studied as a treatment for alcoholism and other addictions.

No comments:

Post a Comment